Purchase Order 15B10926P00000075
- Not listed
- The Federal Medical Center Lexington, a civilian facility under the Bureau of Prisons, awarded a purchase order to McKesson Corporation for multiple medication shipments totaling $18,027.09 in requested funding against a ceiling value of $8,960.80. The contract, issued on February 1, 2026, with an ultimate completion date of March 20, 2026, represents a firm fixed-price procurement with no small business set-aside designation. McKesson, headquartered in Irving, Texas, will perform the work...
- McKesson Corporation, the prime contractor headquartered in Irving, Texas, has been awarded a $17.4M purchase order by the Federal Medical Center Lexington, a civilian facility under the Bureau of Prisons. This firm fixed-price contract, awarded on March 1, 2026, covers multiple invoices for medication shipments required through March 31, 2026. The work will be performed at McKesson's Irving, Texas location, and no small business set-aside designation was utilized in this procurement. This award...
- The Department of Justice Bureau of Prisons Federal Medical Center in Lexington awarded McKesson Corporation a $17,956.85 purchase order to supply medications. Under the terms of the non-contract award, McKesson will ship medications to the correctional facility in Irving, Texas between September 1st and October 23rd, 2023. As the largest pharmaceutical distributor in the U.S., McKesson will fulfill this requirement from their distribution center in Irving. No subcontractors or set-aside...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded McKesson Corporation, doing business as McKesson Drug Company, a $167,305.48 firm fixed price delivery order contract to provide routine wholesale non-controlled and controlled substance medication purchases from October through December 2023. McKesson, a wholly owned subsidiary of McKesson Corporation, will fulfill multiple invoices for medication shipments from its location in Irving, Texas to the Bureau of...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $480,643.73 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from October 1, 2023 through November 20, 2023. Mckesson will supply the Bureau of Prisons facility in Lexington, Kentucky with pharmaceutical products...
- McKesson Corporation has been awarded a delivery order valued at $635,111.49 by the Federal Medical Center Lexington, a civilian facility under the Federal Bureau of Prisons. The delivery order, effective July 1, 2026 through July 31, 2026, is structured as a firm fixed-price contract with no small business set-aside designation. McKesson will supply both controlled and non-controlled pharmaceutical substances to support the medical operations of the federal correctional facility. The award...
- The U.S. Federal Medical Center Lexington, a civilian facility within the Department of Justice, awarded a delivery order to McKesson Corporation for routine wholesale medication purchases valued at $610.7K. This Firm Fixed Price contract covers multiple invoices for controlled and non-controlled pharmaceutical shipments received during the first quarter of fiscal year 2025 (September 1-30, 2025). The contract was awarded without a set-aside designation, reflecting McKesson's status as a large...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $287,645.47 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from November 1, 2022 through December 9, 2022. Mckesson will supply pharmaceutical products to the Federal Medical Center Lexington facility located in...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $356,491.47 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases from June 1, 2022 through September 30, 2022. The place of performance will be Mckesson's location in Irving, Texas. As a leading distributor of pharmaceuticals and medical supplies, Mckesson will supply...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation a $533,000 firm fixed price delivery order contract to provide routine wholesale medication purchases including both non-controlled and controlled substances from May 1, 2023 through May 31, 2023. Mckesson will supply the Bureau of Prisons facility in Lexington, Kentucky with multiple shipments of medications over the one-month period from its location in Irving, Texas as the prime...
The Federal Medical Center Lexington, a civilian facility under the Bureau of Prisons, awarded a $20,149.21 firm fixed-price purchase order to McKesson Corporation for multiple invoices of medication shipments during the period of January 31 through May 31, 2026. The award, issued on May 1, 2026, represents a non-contract account transaction (B1 McKesson Non-Contract Account 010457) with no small business set-aside designation. McKesson, headquartered in Irving, Texas, will perform work from its established pharmaceutical distribution infrastructure to supply medications required for federal correctional healthcare operations. This purchase order reflects McKesson's established role as a critical pharmaceutical supplier to the Federal Bureau of Prisons system, where the company maintains an extensive portfolio of delivery orders and purchase orders supporting controlled and non-controlled medications to correctional facilities nationwide. McKesson's federal contract engagement with the Bureau of Prisons spans multiple institutions and individual awards ranging substantially in value, positioning the company as a major healthcare services and pharmaceutical distribution provider to federal correctional healthcare operations. The firm fixed-price structure and specific completion date of May 31, 2026, establish definitive performance parameters for medication delivery to this Federal Medical Center location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 4/12/26 |